One Year of Real-Life Practice in Treatment Strategies and Future Exacerbation among Asthma Patients with Exacerbation Required Emergency Department Visits
Abstract
Objective: To investigate the treatment patterns and clinical outcomes regarding future exacerbation in patients with a history of emergency department (ED) visited exacerbation.
Material and Methods: We analyzed the treatment patterns and moderate/severe asthma exacerbation rates over a year. The Kaplan-Meier method was used to determine the probability of an asthma exacerbation, and the time to the first exacerbation was compared.
Results: Of the 155 patients, 59 (38.1%) had naïve treatment, 53 (34.2%) and 43 (27.7%) received GINA-classified steps 1-2 and 3-5 treatments, respectively. Approximately 50% of those with naïve treatment lost adherence after a year of follow-up. However, the annual moderate/severe exacerbation rate was reported as the lowest and increased from 0.34 to 0.49 (p-value=0.236) compared to those with steps 1-2 and 3-5 treatments, from 0.66 to 0.47 (p-value=0.085) and 3.00 to 1.19 (p-value=0.006), respectively. Patients with GINA-classified steps 3-5 treatment were prescribed controllers 10.9 more than the 7.8 canisters prescribed to those with naïve treatment (p-value<0.001). In contrast, there were no differences in total reliever prescriptions between the groups (p-value=0.274). Finally, there was no significant difference in the likelihood of having future exacerbations (p-value=0.107). The estimated time of exacerbation in naïve treatment, GINA-classified steps 1-2, and 3-5 treatment were 42.2, 36.6, and 34.2 weeks, respectively.
Conclusion: This study confirms that the frequency of future exacerbations following an ED-visited exacerbation increases as the stepwise treatment increases. This finding may help clinicians understand the natural history of treatment patterns and exacerbation outcomes. Patients with naïve treatment may have a unique history of significantly less exacerbation despite discontinuing controllers.
Keywords
Full Text:
PDFReferences
The Global Asthma Report. Int J Tuberc Lung Dis 2022;26: S1–102.
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, updated 2024 [homepage on the Internet]. Fontainebleau: Global Initiative for Asthma; 2024 [cited 2024 Nov 23]. Available from: http://www.ginasthma.org
Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and al-lergic rhinitis in a general population. Respir Med 2006;100:354-62.
Zewudie A, Nigussie T, Mamo Y, Kumela K. Determinants of poorly controlled asthma among asthmatic patients in Jimma University Medical Center, Southwest Ethiopia: a case control study. BMC Res Notes 2019;12:525.
Tomisa G, Horváth A, Szalai Z, Müller V, Tamási L. Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study. J Asthma Al-lergy 2019;12:297-307.
Hasegawa K, Sullivan AF, Tsugawa Y, Turner SJ, Massaro S, Clark S, et al. Comparison of U.S. emergency department acute asthma care quality: 1997-2001 and 2011-2012. J Allergy Clin Immunol 2015;135:73-80.
Losappio L, Heffler E, Carpentiere R, Fornero M, Cannito CD, Guerrera F, et al. "Characteris-tics of patients admitted to emergency department for asthma attack: a real-LIFE study". BMC Pulm Med 2019;19:107.
Hasegawa K, Sullivan AF, Tovar Hirashima E, Gaeta TJ, Fee C, Turner SJ, et al. A multicenter observational study of U.S. adults with acute asthma: who are the frequent users of the emergency department? J Allergy Clin Immunol Pract 2014;2:733-40.
Kajioka EH, Itoman EM, Li ML, Taira DA, Li GG, Yamamoto LG. Pediatric prescription pick-up rates after E.D. visits. Am J Emerg Med 2005;23:454-8.
Leickly FE, Wade SL, Crain E, Kruszon-Moran D, Wright EC, Evans R. Self-reported adher-ence, managing behavior and barriers to care after an emergency department visit by inner city chil-dren with asthma. Pediatrics 1998;101:e8.
Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE; TENOR Study Group. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 2005;116:990-5.
Nakwan N. Impact of asthma severity as risk factor to future exacerbations in patients admitted for asthma exacerbation. Multidiscip Respir Med 2021;16:780.
Kang MG, Kim JY, Jung JW, Song WJ, Cho SH, Min KU, et al. Lost to follow-up in asthmat-ics does not mean treatment failure: causes and clinical outcomes of non-adherence to outpatient treatment in adult asthma. Allergy Asthma Immunol Res 2013;5:357-64.
Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerba-tions: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59–99.
Nittala A, Nahmens I, Ikuma L, Thomas D. Evaluating lean implementation and hospital performance: a systematic review. J Healthc Qual Res 2019;34:301-7.
Backer V, Harving H, Søes-Petersen U, Ulrik CS, Plaschke P, Lange P. Treatment and eval-uation of patients with acute exacerbation of asthma before and during a visit to the E.R. in Denmark. Clin Respir J 2008;2:54-9.
Tomisa G, Horváth A, Sánta B, Keglevich A, Tamási L. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 2021;17:95.
Schatz M, Zeiger RS, Vollmer WM, Mosen D, Mendoza G, Apter AJ, et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 2006;130:43-50.
Yawn BP, Wollan PC, Bertram SL, Lowe D, Butterfield JH, Bonde D, et al. Asthma treatment in a population-based cohort: putting step-up and step-down treatment changes in context. Mayo Clin Proc 2007;82:414-21.
Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J 2015;45:396-407.
Davis J, Trudo F, Siddall J, Small M. Burden of asthma among patients adherent to ICS/LABA: a real-world study. J Asthma 2019;56:332-40.
Foster JM, Usherwood T, Smith L, Sawyer SM, Xuan W, Rand CS, et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol 2014;134:1260–8.
Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propio-nate/salmeterol combination therapy. J Allergy Clin Immunol 2006;118:899–904.
Busse WW, Fang J, Marvel J, Tian H, Altman P, Cao H. Uncontrolled asthma across GINA treatment steps 2-5 in a large US patient cohort. J Asthma 2022;59:1051-62.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.